Heart Disease Today

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. [click link for […]

** CORONA is the first ever multi-national, prospective outcomes study to determine the impact of statin treatment on heart failure. The goal of the CORONA study is to determine the effect of CRESTOR 10 mg on a combined endpoint of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke in patients with chronic heart […]